BAP1 and renal cell carcinoma: Among 29 SMGs in RCC, only BAP1 showed a statistically significant increase in the mutational frequency from RCC specimens of patients without ACKD as compared to those with ACKD (10.6% versus 1.6%, respectively; p = 0.050).